SSX2 Antibody (1A4)

This product is produced by and distributed for Abnova, a company based in Taiwan.

The product of this gene belongs to the family of highly homologous synovial sarcoma X (SSX) breakpoint proteins. These proteins may function as transcriptional repressors. They are also capable of eliciting spontaneously humoral and cellular immune responses in cancer patients, and are potentially useful targets in cancer vaccine-based immunotherapy. SSX1, SSX2 and SSX4 genes have been involved in the t(X;18) translocation characteristically found in all synovial sarcomas. This translocation results in the fusion of the synovial sarcoma translocation gene on chromosome 18 to one of the SSX genes on chromosome X. The encoded hybrid proteins are probably responsible for transforming activity. Two transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq]

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Showing Publications 1 - 2 of 2.

Publications using H00006757-M01	Applications	Species
Greve KB, Pohl M, Olsen KE et al. SSX2-4 expression in early-stage non-small cell lung cancer. Tissue Antigens. 2014-03-20 [PMID: 24645645]
Smith HA, Cronk RJ, Lang JM et al. Expression and Immunotherapeutic Targeting of the SSX Family of Cancer-Testis Antigens in Prostate Cancer. Cancer Res 2011-09-07 [PMID: 21880588]

Images	Ratings	Applications	Species	Date	Details
Enlarge	5 reviewed by: morten gjerstorff	IF	Human	11/17/2015	View Summary Application Immunofluorescence Species Human

Array H00006757-M01

• SSX2 Antibodies
• SSX2 Lysates
• SSX2 Proteins